Bayer AG is assessing alternatives to carry merchandise addressing uncomfortable side effects related to glucagon-like peptide-1 (GLP-1) weight problems medicine ...
The Medicine Controller of India has intensified its regulatory surveillance to uphold moral pharmaceutical practices throughout the GLP-1 weight reduction ...